Ozurdex as Adjunct to Avastin Compared to Avastin Alone in Treatment of Patients With Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
Bevacizumab for Neovascular Age-related Macular Degeneration
- Status
- COMPLETED
- Phase
- NA
Bevacizumab With or Without Fosbretabulin Tromethamine in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
- Status
- COMPLETED
- Phase
- PHASE2
1st Line Treatment of Bevacizumab-Taxane vs Bevacizumab-Exemestane in Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Efficacity of Weekly Paclitaxel in Association or Not With Bevacizumab in Metastatic or Locally Advanced Angiosarcomas
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Safety and Pharmacology of GDC-0980 in Combination With Either Paclitaxel and Carboplatin (With or Without Bevacizumab) or Pemetrexed and Cisplatin in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Intravitreal Bevacizumab (Avastin®) Versus Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema
- Status
- COMPLETED
- Phase
- PHASE2
Intralesional Bevacizumab for Treating AIDS-associated Kaposi´s Sarcoma of the Larynx, Pharynx and Oral Cavity
- Status
- COMPLETED
- Phase
- PHASE2
Carboplatin and Bevacizumab for Recurrent Ependymoma
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab and Lomustine for Recurrent GBM
- Status
- COMPLETED
- Phase
- PHASE3
Amgen 386 for Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Randomized Controlled Trial of Subconjunctival Bevacizumab Injection in Impending Recurrent Pterygium
- Status
- COMPLETED
- Phase
- NA
Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- NA
Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Study of REOLYSIN® in Combination With FOLFIRI and Bevacizumab in FOLFIRI Naive Patients With KRAS Mutant Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of Interleukin-2, Interferon-alpha and Bevacizumab in Metastatic Kidney Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Combination Chemotherapy and Bevacizumab With or Without RO4929097 in Treating Patients With Metastatic Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Phase I/II Adaptive Randomized Trial of Bevacizumab Versus Bevacizumab Plus Vorinostat in Adults With Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Efficacy and Safety of Bevacizumab/Temsirolimus Combination to Treat Advanced Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2